Royal Marsden Joins AI Revolution with New Radiology Analysis to Transform Cancer Research

May 27, 2025
Royal Marsden Joins AI Revolution with New Radiology Analysis to Transform Cancer Research
  • Research will utilize anonymized data in collaboration with the Institute of Cancer Research to assess the accuracy and efficiency of AI tools in a clinical research setting.

  • Tom Winstanley, CTO at NTT DATA, praised the initiative as a responsible innovation that showcases the ethical application of AI in healthcare.

  • Health Minister Karin Smyth emphasized that this collaboration is part of the NHS's modernization efforts, aligning with the 10 Year Health Plan to enhance healthcare through digital innovations.

  • In a related development, Evariste, an AI-driven drug discovery company, recently partnered with the University of Southampton to create a large transcriptomic dataset for esophageal adenocarcinoma, further showcasing advancements in cancer research.

  • The service operates on a specialized MLOps clinical imaging platform developed by NTT DATA, featuring high-performance Dell servers and advanced GPU processing capabilities managed by CARPL.ai.

  • This service includes tools for monitoring the performance of AI models over time, streamlining the development and evaluation process.

  • The Royal Marsden is recognized as one of the leading cancer research centers globally, established in 1851 and operating in partnership with the Institute of Cancer Research.

  • The Royal Marsden NHS Foundation Trust has teamed up with NTT DATA and CARPL.ai to introduce an AI-powered radiology analysis service aimed at advancing cancer research.

  • Professor Dow-Mu Koh highlighted the project's potential to transform cancer diagnosis and treatment, creating a scalable research environment that could significantly improve patient care.

  • CARPL.ai's platform will facilitate the management and testing of various radiology AI models, providing essential access for evaluation.

  • The primary goal is to create a controlled environment for rigorous testing of AI models, allowing for thorough evaluation before any deployment in patient care.

  • The centralized interface from CARPL.ai will enable real-time monitoring of AI model performance, establishing faster feedback loops crucial for clinical application.

Summary based on 15 sources


Get a daily email with more AI stories

More Stories